Cargando…

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival

We have previously shown that rat allogeneic DC, made immature by adenoviral gene transfer of the dominant negative form of IKK2, gave rise in-vitro to a unique population of CD4(+)CD25(−) regulatory T cells (dnIKK2-Treg). These cells inhibited Tcell response in-vitro, without needing cell-to-cell c...

Descripción completa

Detalles Bibliográficos
Autores principales: Aiello, Sistiana, Rocchetta, Federica, Longaretti, Lorena, Faravelli, Silvia, Todeschini, Marta, Cassis, Linda, Pezzuto, Francesca, Tomasoni, Susanna, Azzollini, Nadia, Mister, Marilena, Mele, Caterina, Conti, Sara, Breno, Matteo, Remuzzi, Giuseppe, Noris, Marina, Benigni, Ariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599553/
https://www.ncbi.nlm.nih.gov/pubmed/28912528
http://dx.doi.org/10.1038/s41598-017-08617-3
Descripción
Sumario:We have previously shown that rat allogeneic DC, made immature by adenoviral gene transfer of the dominant negative form of IKK2, gave rise in-vitro to a unique population of CD4(+)CD25(−) regulatory T cells (dnIKK2-Treg). These cells inhibited Tcell response in-vitro, without needing cell-to-cell contact, and induced kidney allograft survival prolongation in-vivo. Deep insight into the mechanisms behind dnIKK2-Treg-induced suppression of Tcell proliferation remained elusive. Here we document that dnIKK2-Treg release extracellular vesicles (EV) riched in exosomes, fully accounting for the cell-contact independent immunosuppressive activity of parent cells. DnIKK2-Treg-EV contain a unique molecular cargo of specific miRNAs and iNOS, which, once delivered into target cells, blocked cell cycle progression and induced apoptosis. DnIKK2-Treg-EV-exposed T cells were in turn converted into regulatory cells. Notably, when administered in-vivo, dnIKK2-Treg-EV prolonged kidney allograft survival. DnIKK2-Treg-derived EV could be a tool for manipulating the immune system and for discovering novel potential immunosuppressive molecules in the context of allotransplantation.